The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $818,360 in first-year total cost, median $818,360.
Most frequent study sections
- Special Emphasis Panel[ZNS1 SRB-Q (12)]1
Most frequent institutions
- UNIVERSITY OF SOUTHERN CALIFORNIA1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Development of Angiotensin AT2 inhibitors for neuropathic pain relief1UG3NS143065-01 | CHEREZOV, VADIMKATRITCH, VSEVOLODMAJUMDAR, SUSRUTASHEPHERD, ANDREW JOHN | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $818,360 | ZNS1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.